Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

MT Newswires Live
Yesterday

Asian equities traded in the US as American depositary receipts were edging slightly lower Tuesday morning, declining 0.14% to 3,020.40 on the S&P Asia 50 ADR Index.

From North Asia, the gainers were led by diagnostic imaging centers company Concord Medical Services (CCM) and biopharmaceutical company Zai Lab (ZLAB), which rose 5.5% and 5.4% respectively. They were followed by education company 17 Education & Technology Group (YQ) and game live-streaming service HUYA (HUYA), which advanced 4.2% and 3.9% respectively.

The decliners from North Asia were led by music streaming service Tencent Music Entertainment Group (TME) and electric vehicle maker NIO (NIO), which dropped 12% and 6% respectively. They were followed by online retailer JD.com (JD) and video-sharing platform Bilibili (BILI), which were down 4.8% and 4.7% respectively.

From South Asia, the gainers were led by tech conglomerate Sea (SE) and pharmaceutical company Dr. Reddy's Laboratories (RDY), which climbed 11% and 3.1% respectively. They were followed by computer hardware maker Canaan (CAN) and lender HDFC Bank (HDB), which increased 1.4% and 1% respectively.

The decliners from South Asia were led by telecommunications operator PT Telekomunikasi Indonesia (TLK) and IT firm Sify Technologies (SIFY), which lost 1.7% and 0.7% respectively. They were followed by IT company Wipro (WIT) and telecommunications operator PLDT (PHI), which were off 0.5% and 0.3% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10